Viokase 16 (pancrelipase) + Nexium ( DrugBank: Pancrelipase )


1 disease
IDDisease name (Link within this page)Number of trials
298Hereditary pancreatitis1

298. Hereditary pancreatitis


Clinical trials : 95 Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01142128
(ClinicalTrials.gov)
February 20099/6/2010Viokase 16, Viokase16 Plus Nexium and Nexium AloneA Randomized, Single Site, Double Blind, Fixed Dose, Cross Over Study of Viokase 16, Viokase16 Plus Nexium and Nexium Alone in the Reduction of Abdominal Pain in Patients With Chronic PancreatitisChronic PancreatitisDrug: Nexium (esomeprazole magnesium);Drug: Placebo to Nexium;Drug: Viokase 16 (pancrelipase) + Nexium;Drug: Viokase 16 + placebo to NexiumUniversity of FloridaAstraZenecaTerminated18 Years75 YearsAll12Phase 1United States